AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma.
Hepatology (Baltimore, Md.) · 2023 · 350 citations · James Tabibian
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.
Transplantation and cellular therapy · 2023 · 331 citations · Nirav Shah
Pan-UK Biobank genome-wide association analyses enhance discovery and resolution of ancestry-enriched effects.
Nature genetics · 2025 · 97 citations · Nirav Shah
Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma.
World journal of gastroenterology · 2022 · 269 citations · Hira Hanif
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.
Lancet (London, England) · 2021 · 391 citations · Nirav Shah
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.
The New England journal of medicine · 2023 · 204 citations · Nirav Shah
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study.
Blood · 2021 · 295 citations · Nirav Shah
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy.
Blood · 2024 · 124 citations · Nirav Shah